ESG

The security tech firm expands its domestic violence monitoring to a 10th nation, signaling a major shift in Europe's public safety technology market.

CleanSpark boosts Bitcoin output by over 10% and pivots to AI data centers, all while helping stabilize the power grid in times of extreme demand.

The fintech disruptor is slashing onboarding times and boosting approvals for banks, signaling a new era of AI-driven efficiency and financial inclusion.

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

With trust in health guidance waning, consumers demand clarity. See how supplement brands are using radical transparency to win back confidence.

With enrollment complete for three major trials, MediciNova braces for a transformative year with crucial data expected for its ALS and metabolic disease candidates.

STAAR Surgical stockholders rejected a lucrative Alcon merger, betting on the standalone potential of their EVO ICL lenses despite recent financial headwinds.

WK Kellogg Co is betting big on its first Super Bowl ad for Raisin Bran, using a mystery celebrity to spotlight a national health issue. Will it work?

Capitol Meridian and Stellex acquire survival gear maker Beaufort, positioning it for major growth and innovation with new investment and veteran leadership.

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

North Coast Credit Union partners with Mahalo Banking, leveraging deep core integration and pioneering neurodiverse features to transform its member experience.

A new antibody-drug conjugate, DEM301, shows preclinical promise by targeting a unique protein to directly kill tumors and unleash the immune system.

With its first drug for a rare disease now on the market, Stealth BioTherapeutics bets its future on a deep pipeline targeting mitochondrial dysfunction.

Newcomer Candid Therapeutics is set to unveil its T-cell engager platform at J.P. Morgan, a move that could shake up the autoimmune treatment landscape.

A new report reveals a historic drop in line-of-duty deaths, but experts point to a complex picture of improved survival and persistent risks.

BizClik announces its AI LIVE London Summit for 2026, aiming to cut through the hype with a focus on enterprise reality in a crowded global tech scene.

A validated dry EEG headset provides a scalable, objective measure of brain plasticity, promising to accelerate drug discovery for Alzheimer's and depression.

At CES 2026, a landmark deal was struck to bring autonomous delivery vans to Europe, with Portugal set to become the continent's primary testbed.

Early trial data for IKS014 reveals a high clinical benefit rate in pre-treated oesophageal cancer, offering a new beacon of hope for a hard-to-treat disease.